Sezary Syndrome Global Clinical Trials Review, H1, 2012

Published: February 2012 No. of Pages: 77 Price: US$1000

GlobalData's clinical trial report, Sezary Syndrome Global Clinical Trials Review, H1, 2012" provides data on the Sezary Syndrome clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Sezary Syndrome. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Sezary Syndrome. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts. Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope y Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type Listings of discontinued trials (suspended, withdrawn and terminated)

y y

Reasons to buy y y y y Understand the dynamics of a particular indication in a condensed manner Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more Obtain discontinued trial listing for trials across the globe Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies Sezary Syndrome Clinical Trials Table of Contents y Table of Contents 2 List of Tables 4 List of Figures 5 Introduction 6 Sezary Syndrome 6 Report Guidance 6 Clinical Trials by Region 7 Clinical Trials by Country 8

Top Countries Contributing to Clinical Trials in Asia-Pacific 10 Top Five Countries Contributing to Clinical Trials in Europe 11 Top Countries Contributing to Clinical Trials in North America 12 Clinical Trials by BRIC Nations 13 Clinical Trials by G7 Nations 14 Clinical Trials in G7 Nations by Trial Status 15 Clinical Trials by E7 Nations 16 Clinical Trials in E7 Nations by Trial Status 17 Clinical Trials by Phase 18 In Progress Trials by Phase 19 Clinical Trials by Trial Status 20 Unaccomplished Trials of Sezary Syndrome 21 Subjects Recruited Over a Period of Time 24 Prominent Sponsors 25 Top Companies Participating in Sezary Syndrome Therapeutics Clinical Trials 27 Prominent Drug Comparison 28 Clinical Trial Profiles 29 Clinical Trial Overview of Top Companies 29 Eisai Inc. 29 Clinical Trial Overview of Eisai Inc. 29 TSD Japan, Inc. 30 Clinical Trial Overview of TSD Japan, Inc. 30 Allos Therapeutics, Inc. 31 Clinical Trial Overview of Allos Therapeutics, Inc. 31 Clinical Trial Overview of Top Universities / Institutes / Hospitals 32 Fred Hutchinson Cancer Research Center 32 Clinical Trial Overview of Fred Hutchinson Cancer Research Center 32 Northwestern University 33 Clinical Trial Overview of Northwestern University 33 Case Comprehensive Cancer Center 34 Clinical Trial Overview of Case Comprehensive Cancer Center 34 Hahnemann University Hospital 35 Clinical Trial Overview of Hahnemann University Hospital 35 City of Hope National Medical Center 36 Clinical Trial Overview of City of Hope National Medical Center 36 Ohio State University Comprehensive Cancer Center 37 Clinical Trial Overview of Ohio State University Comprehensive Cancer Center 37 Scott & White Healthcare 38 Clinical Trial Overview of Scott & White Healthcare 38 Mayo Clinic 39 Clinical Trial Overview of Mayo Clinic 39 Wake Forest University 40 Clinical Trial Overview of Wake Forest University 40 Barbara Ann Karmanos Cancer Institute 41 Clinical Trial Overview of Barbara Ann Karmanos Cancer Institute 41 Stanford University 42 Clinical Trial Overview of Stanford University 42 Assistance Publique - Hopitaux de Paris 43 Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 43 University of Pittsburgh 44 Clinical Trial Overview of University of Pittsburgh 44 Five Key Clinical Profiles 45 Appendix 74 Abbreviations 74 Definitions 74 Research Methodology 75

y y

Secondary Research 75 About GlobalData 76 Contact Us 76 Disclaimer 76 Source 77 List of Tables Sezary Syndrome Therapeutics Market, Global, Clinical Trials by Zone, 2012* 7 Sezary Syndrome Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 8 Sezary Syndrome Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 9 Sezary Syndrome Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2012* 10 Sezary Syndrome Therapeutics Clinical Trials, Europe, Top Five Countries, 2012* 11 Sezary Syndrome Therapeutics Clinical Trials, North America, Top Countries, 2012* 12 Sezary Syndrome Therapeutics Clinical Trials, BRIC Countries, 2012* 13 Sezary Syndrome Therapeutics Clinical Trials, G7 Countries, 2012* 14 Sezary Syndrome Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 15 Sezary Syndrome Therapeutics Clinical Trials, E7 Countries, 2012* 16 Sezary Syndrome Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 17 Sezary Syndrome Therapeutics Market, Global, Clinical Trials by Phase, 2012* 18 Sezary Syndrome Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012* 19 Sezary Syndrome Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 20 Sezary Syndrome Therapeutics Market, Global, Suspended Clinical Trials, 2012* 21 Sezary Syndrome Therapeutics Market, Global, Withdrawn Clinical Trials, 2012* 22 Sezary Syndrome Therapeutics Market, Global, Terminated Clinical Trials, 2012* 23 Sezary Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 20052010 24 Sezary Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 26 Sezary Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 27 Sezary Syndrome Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 28 Sezary Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Inc., 2012* 29 Sezary Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by TSD Japan, Inc., 2012* 30 Sezary Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Allos Therapeutics, Inc., 2012* 31 Sezary Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center, 2012* 32 Sezary Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Northwestern University, 2012* 33 Sezary Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Case Comprehensive Cancer Center, 2012* 34 Sezary Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Hahnemann University Hospital, 2012* 35 Sezary Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by City of Hope National Medical Center, 2012* 36 Sezary Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Ohio State University Comprehensive Cancer Center, 2012* 37 Sezary Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Scott & White Healthcare, 2012* 38 Sezary Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2012* 39 Sezary Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Wake Forest University, 2012* 40 Sezary Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Barbara Ann Karmanos Cancer Institute, 2012* 41

y y

Sezary Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2012* 42 Sezary Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2012* 43 Sezary Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2012* 44 List of Figures Sezary Syndrome Therapeutics Market, Global, Clinical Trials by Zone (%), 2012* 7 Sezary Syndrome Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 8 Sezary Syndrome Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 9 Sezary Syndrome Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2012* 10 Sezary Syndrome Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012* 11 Sezary Syndrome Therapeutics Clinical Trials, North America, Top Countries (%), 2012* 12 Sezary Syndrome Therapeutics Clinical Trials, G7 Countries (%), 2012* 14 Sezary Syndrome Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 15 Sezary Syndrome Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 17 Sezary Syndrome Therapeutics Market, Global, Clinical Trials by Phase (%), 2012* 18 Sezary Syndrome Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012* 19 Sezary Syndrome Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 20 Sezary Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 20052010 24 Sezary Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 25 Sezary Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 27 Sezary Syndrome Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 28 GlobalData Methodology 75